Xue-Song Sun

Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II–IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial

Lin-Quan Tang, Dong-Ping Chen, Ling Guo et al. · The Lancet Oncology · 2018 · 150 citations

Medicine, Oncology, Radiation Oncology +14

Future of Radiotherapy in Nasopharyngeal Carcinoma

Xue-Song Sun, Xiao-Yun Li, Qiu-Yan Chen et al. · British Journal of Radiology · 2019 · 138 citations · Full text

Medicine, Oncology, Radiation Oncology +17

The Association Between the Development of Radiation Therapy, Image Technology, and Chemotherapy, and the Survival of Patients With Nasopharyngeal Carcinoma: A Cohort Study From 1990 to 2012

Xue-Song Sun, Sai‐Lan Liu, Mei-Juan Luo et al. · International Journal of Radiation Oncology*Biology*Physics · 2019 · 129 citations · Full text

Medicine, Oncology, Radiation Oncology +14

Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients based on induction chemotherapy response

Sai‐Lan Liu, Xue-Song Sun, Jin‐Jie Yan et al. · Radiotherapy and Oncology · 2019 · 69 citations

Medicine, Oncology, Pharmacology +14

Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trial

Yuan Li, Guo-Dong Jia, Xiaofei Lv et al. · Nature Communications · 2023 · 49 citations · Full text

Medicine, Oncology, Pharmacology +13